Evidence map›Paper›PMID 33434426›Full record

ArticleDiabetes & metabolism journal2021

Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status.

Chan-Hee Jung, Jang Won Son, Shinae Kang, Won Jun Kim, Hun-Sung Kim, Hae Soon Kim, Mihae Seo, Hye-Jung Shin, Seong-Su Lee, Su Jin Jeong and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes & metabolism journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Chan-Hee JungDivision of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
Jang Won SonDivision of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
Shinae KangDepartment of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Won Jun KimDepartment of Endocrinology and Metabolism, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.
Hun-Sung KimDepartment of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Hae Soon KimDepartment of Pediatrics, Ewha Womans University School of Medicine, Seoul, Korea.
Mihae SeoDepartment of Endocrinology and Metabolism, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine, Gumi, Korea.
Hye-Jung ShinDepartment of Pediatrics, National Medical Center, Seoul, Korea.
Seong-Su LeeDivision of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
Su Jin JeongDepartment of Endocrinology and Metabolism, Sejong General Hospital, Bucheon, Korea.
Yongin ChoDepartment of Endocrinology and Metabolism, Inha University School of Medicine, Incheon, Korea.
Seung Jin HanDepartment of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea.
Hyang Mi JangDepartment of Nursing, Gangnam Severance Hospital, Yonsei University, Seoul, Korea.
Mira RhoDepartment of Nutrition, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
Shinbi LeeDepartment of Clinical Nutrition, Korea University Anam Hospital, Seoul, Korea.
Mihyun KooDepartment of Social Work, Samsung Medical Center, Seoul, Korea.
Been YooDepartment of Social Work, Kyung Hee University Hospital at Gangdong, Seoul, Korea.
Jung-Wha MoonDepartment of Sports Medical Center, Inje University Ilsan Paik Hospital, Goyang, Korea.
Hye Young LeeSport Health Medicine Center, Asan Medical Center, Seoul, Korea.
Jae-Seung YunDivision of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Sun Young KimDepartment of Nursing, Samsung Medical Center, Seoul, Korea.
Sung Rae KimDivision of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
In-Kyung JeongDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.
Ji-Oh MokDivision of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
Kun Ho YoonDivision of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, the Catholic University of Korea, Seoul, Korea.

Funding

The Korean Diabetes Association
6 · The paper itself

Abstract

backgroundThis study aimed to investigate the recent prevalence, management, and comorbidities of diabetes among Korean adults aged ≥30 years by analyzing nationally representative data.

methodsThis study used data from the Korea National Health and Nutrition Examination Survey from 2016 to 2018, and the percentage and total number of people ≥30 years of age with diabetes and impaired fasting glucose (IFG) were estimated.

resultsIn 2018, 13.8% of Korean adults aged ≥30 years had diabetes, and adults aged ≥65 years showed a prevalence rate of 28%. The prevalence of IFG was 26.9% in adults aged ≥30 years. From 2016 to 2018, 35% of the subjects with diabetes were not aware of their condition. Regarding comorbidities, 53.2% and 61.3% were obese and hypertensive, respectively, and 72% had hypercholesterolemia as defined by low-density lipoprotein cholesterol (LDL-C) ≥100 mg/dL in people with diabetes. Of the subjects with diabetes, 43.7% had both hypertension and hypercholesterolemia. With regard to glycemic control, only 28.3% reached the target level of <6.5%. Moreover, only 11.5% of subjects with diabetes met all three targets of glycosylated hemoglobin, blood pressure, and LDL-C. The percentage of energy intake from carbohydrates was higher in diabetes patients than in those without diabetes, while that from protein and fat was lower in subjects with diabetes.

conclusionThe high prevalence and low control rate of diabetes and its comorbidities in Korean adults were confirmed. More stringent efforts are needed to improve the comprehensive management of diabetes to reduce diabetes-related morbidity and mortality.

Indexed as

Diabetes MellitusAdultCross-Sectional StudiesGlycated HemoglobinHumansNutrition SurveysRepublic of KoreaGlycated HemoglobinComorbidityDiabetes mellitusHypercholesterolemiaHypertensionPrediabetic statePrevalence

Identifiers

PMID33434426
PMCPMC7850879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.